Stay updated on Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; this update does not change any study details, eligibility criteria, locations, or outcomes displayed on the page.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision number updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 has been added, and the previous funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check60 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operating status was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check67 days agoChange DetectedUI text updates were applied, adding 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page now displays Revision: v3.3.4 in place of Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After Salvage Resection in Head and Neck Cancer Clinical Trial page.